Treatment Patterns of Metastatic Triple-Negative Breast Cancer in US Community Practice Settings

Neal P. Christiansen, MD; Lei Chen, MD, PhD; and Hsingwen Chung, BS Pharm, MS
Published: Wednesday, Apr 18, 2012


Objective: To determine actual first-line treatment patterns for metastatic triple-negative breast cancer (mTNBC) in the United States by analyzing records of patients treated in community practices.

Methods: We derived our data from the Georgia Cancer Specialist Database (GCSD) (2003-2008) and the International Oncology Network’s (ION) Treatment and Outcomes Database (2003-2008). In both data sets, patients with stage IV TNBC were selected and followed for up to 1 year after the initial mTNBC diagnosis. Chemotherapy was deemed first-line if initiated within 120 days of mTNBC diagnosis.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Enduring CME activity from the School of Breast Oncology®: 2018 Mid-Year Video UpdateSep 28, 20192.0
Community Practice Connections™: 2nd Annual School of Nursing Oncology™Sep 28, 20191.5
Publication Bottom Border
Border Publication